Skip to main content
Erschienen in: Acta Diabetologica 1/2010

01.12.2010 | Original Article

Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus

verfasst von: Ivan Gornik, Ana Vujaklija, Edita Lukić, Goran Madžarac, Vladimir Gašparović

Erschienen in: Acta Diabetologica | Sonderheft 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Hyperglycaemia caused by stress and inflammation is common during critical illness. We hypothesised that a latent glucose metabolism disturbance contributes to development of hyperglycaemia and that those patients have increased risk for diabetes. We included patients with sepsis, acute coronary syndrome and acute heart failure with no history of impaired glucose metabolism and divided them in the hyperglycaemia group (glucose ≥ 7.8 mmol/l) and normoglycaemia group. Patients were followed for 5 years. Follow-up was completed for 115 patients in the normoglycaemia group, of which 4 (3.5%) developed type 2 diabetes. In the hyperglycaemia group 51 patients finished follow-up and 8 (15.7%) developed type 2 diabetes. Relative risk in 5-year period for patients with hyperglycaemia was 4.51 for development of type 2 diabetes. Patients with hyperglycaemia during critical illness who are not diagnosed with diabetes before or during the hospitalisation should be considered a population at increased risk for developing diabetes.
Literatur
1.
Zurück zum Zitat Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554CrossRefPubMed Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554CrossRefPubMed
2.
Zurück zum Zitat Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688CrossRefPubMed Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688CrossRefPubMed
3.
Zurück zum Zitat van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMed van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMed
4.
Zurück zum Zitat Malmberg K, Norhammar A, Wedel H et al (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632PubMed Malmberg K, Norhammar A, Wedel H et al (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632PubMed
5.
Zurück zum Zitat Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528CrossRefPubMed Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528CrossRefPubMed
6.
Zurück zum Zitat Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix
7.
Zurück zum Zitat McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124CrossRefPubMed McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124CrossRefPubMed
8.
Zurück zum Zitat Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559CrossRefPubMed Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559CrossRefPubMed
9.
Zurück zum Zitat Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383CrossRefPubMed Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383CrossRefPubMed
10.
Zurück zum Zitat Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756CrossRefPubMed Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756CrossRefPubMed
11.
Zurück zum Zitat Aljada A, Ghanim H, Assian E et al (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491CrossRefPubMed Aljada A, Ghanim H, Assian E et al (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491CrossRefPubMed
12.
Zurück zum Zitat Mizock BA (2001) Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533–551CrossRefPubMed Mizock BA (2001) Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533–551CrossRefPubMed
13.
Zurück zum Zitat Clowes GH Jr, Martin H, Walji S et al (1978) Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577–583CrossRefPubMed Clowes GH Jr, Martin H, Walji S et al (1978) Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577–583CrossRefPubMed
14.
Zurück zum Zitat Dahn MS, Jacobs LA, Smith S et al (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172PubMed Dahn MS, Jacobs LA, Smith S et al (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172PubMed
15.
Zurück zum Zitat Mehta VK, Hao W, Brooks-Worrell BM et al (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214CrossRefPubMed Mehta VK, Hao W, Brooks-Worrell BM et al (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214CrossRefPubMed
16.
Zurück zum Zitat Metso AJ, Murros K (2007) Hyperglycaemia and the outcome of stroke. Brain 130:e85 (author reply e86)CrossRefPubMed Metso AJ, Murros K (2007) Hyperglycaemia and the outcome of stroke. Brain 130:e85 (author reply e86)CrossRefPubMed
17.
Zurück zum Zitat Cubbon RM, Rajwani A, Abbas A et al (2007) Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 14:666–671CrossRefPubMed Cubbon RM, Rajwani A, Abbas A et al (2007) Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 14:666–671CrossRefPubMed
18.
Zurück zum Zitat American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60 American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60
19.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed
20.
Zurück zum Zitat Pollack CV Jr, Braunwald E (2008) 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51:591–606CrossRefPubMed Pollack CV Jr, Braunwald E (2008) 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51:591–606CrossRefPubMed
21.
Zurück zum Zitat Braunwald E, Antman EM, Beasley JW et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970–1062CrossRefPubMed Braunwald E, Antman EM, Beasley JW et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970–1062CrossRefPubMed
22.
Zurück zum Zitat Goran KP (2007) The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 28:2042 (author reply 2042–2043)CrossRefPubMed Goran KP (2007) The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 28:2042 (author reply 2042–2043)CrossRefPubMed
23.
Zurück zum Zitat Deedwania P, Kosiborod M, Barrett E et al (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619CrossRefPubMed Deedwania P, Kosiborod M, Barrett E et al (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619CrossRefPubMed
24.
Zurück zum Zitat Inzucchi SE, Rosenstock J (2005) Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 28:976–979CrossRefPubMed Inzucchi SE, Rosenstock J (2005) Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 28:976–979CrossRefPubMed
25.
Zurück zum Zitat Bryer-Ash M, Garber AJ (2005) Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 28:973–975CrossRefPubMed Bryer-Ash M, Garber AJ (2005) Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 28:973–975CrossRefPubMed
26.
Zurück zum Zitat Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10(Suppl 2):4–9PubMed Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10(Suppl 2):4–9PubMed
27.
Zurück zum Zitat Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792CrossRefPubMed Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792CrossRefPubMed
Metadaten
Titel
Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus
verfasst von
Ivan Gornik
Ana Vujaklija
Edita Lukić
Goran Madžarac
Vladimir Gašparović
Publikationsdatum
01.12.2010
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe Sonderheft 1/2010
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0115-6

Weitere Artikel der Sonderheft 1/2010

Acta Diabetologica 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.